3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
4
Other
2
Endocrine
2
Tumor-Agnostic
1
NET
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Conditions
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Myeloproliferative Disorders
1
Inflammation
1
Interventions
fludarabine phosphate
140
Cyclophosphamide
132
Busulfan
102
Peripheral Blood Stem Cell Transplantation
95
Imatinib Mesylate
94
Mycophenolic Acid
91
Cytarabine
82
Azacitidine
80
Tacrolimus
79
Cyclosporine
78
Whole-Body Irradiation
77
fludarabine
74
Antilymphocyte Serum
71
Methotrexate
65
Filgrastim
63
nilotinib
59
Melphalan
51
Decitabine
50
Radiotherapy
43
Dasatinib
34
Granulocyte Colony-Stimulating Factor
33
ruxolitinib
31
Clofarabine
31
Etoposide
30
thymoglobulin
29
Thiotepa
29
Cord Blood Stem Cell Transplantation
28
sargramostim
27
Methylprednisolone
26
Stem Cell Transplantation
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diet, Mediterranean
×
Myeloid
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled